{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":32,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":32,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6527942ba211","filters":{"venue":"Journal of health economics and outcomes research"}},"results":[{"id":"W2785965739","doi":"10.36469/9817","title":"Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"LEO Pharma; Astellas Pharma; Mylan; Celgene; Eli Lilly and Company; Valeant Pharmaceuticals International; Pfizer; National Psoriasis Foundation","keywords":"Psoriasis; Tolerability; Medicine; Adverse effect; Logistic regression; Preference; Quality of life (healthcare); Internal medicine; Physical therapy; Statistics; Dermatology","authors":[{"name":"Steven R. Feldman","is_ca":false},{"name":"Anders Holmen Moeller","is_ca":false},{"name":"Sandra T. Erntoft Idemyr","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07272751935305925,"gpt":0.3735386163132736,"spread":0.3008110969602144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002485537,0.0001310126,0.0001905995,0.0003756266,0.0002531784,0.0006063444,0.0001123877,0.000405699,0.00231684],"category_scores_gemma":[0.00736434,0.0001106933,0.0003986845,0.0003530473,0.0003094557,0.0003076976,0.0002952252,0.0005415822,0.0001348304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000345686,"about_ca_system_score_gemma":0.000225191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001900291,"about_ca_topic_score_gemma":0.002986314,"domain_scores_codex":[0.9983998,0.001095594,0.0001063077,0.00009232164,0.000207996,0.0000979794],"domain_scores_gemma":[0.9942246,0.003212429,0.001814851,0.000131023,0.0002318872,0.0003850867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00125701,0.0002263232,0.9809182,0.00003780225,0.0001332952,0.0001022923,0.000742895,0.000384784,0.0006774104,0.0001276484,0.0003414004,0.01505095],"study_design_scores_gemma":[0.0001012534,0.0006946953,0.9926092,0.00004008866,0.00009593603,0.0006508392,0.002153163,0.002401319,0.0002814851,0.000302414,0.0006473493,0.00002220749],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992454,0.0001076502,0.00005417978,0.0001017773,0.000002195824,0.000004865886,0.00003336246,7.733912e-7,0.0004498851],"genre_scores_gemma":[0.9998342,0.00003161429,0.00004590999,0.00003806853,0.000001984367,0.000002423149,0.00001679625,3.452514e-7,0.0000286637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002485537,"threshold_uncertainty_score":0.01314497,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346554787","doi":"10.36469/9831","title":"How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines","year":2015,"lang":"en","type":"review","venue":"Journal of health economics and outcomes research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Type 2 diabetes; Excellence; Markov model; Psychological intervention; Cohort; Nice; Computer science; Gerontology; Diabetes mellitus; Markov chain; Machine learning","authors":[{"name":"Lindsay Govan","is_ca":false},{"name":"Olívia Wu","is_ca":false},{"name":"Robert S. Lindsay","is_ca":false},{"name":"Andrew Briggs","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7979155451812675,"gpt":0.5938924688310505,"spread":0.204023076350217,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03851712,0.002626038,0.006505231,0.01675395,0.0007055054,0.006432258,0.005241141,0.004191184,0.003877146],"category_scores_gemma":[0.1422026,0.001933321,0.008996217,0.01590313,0.001421241,0.006395211,0.002081264,0.00574255,0.0008201369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01240487,"about_ca_system_score_gemma":0.01114048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01420717,"about_ca_topic_score_gemma":0.01094964,"domain_scores_codex":[0.9744533,0.01374018,0.005942548,0.001090442,0.004354751,0.0004186842],"domain_scores_gemma":[0.8993587,0.08627399,0.005708858,0.001143802,0.006992665,0.0005220847],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003790513,0.0001393585,0.002416279,0.1893673,0.004456942,0.0001376279,0.0003916663,0.009072746,0.00006055151,0.06117557,0.0905626,0.6418404],"study_design_scores_gemma":[0.0003110071,0.000156431,0.003385728,0.574563,0.006475493,0.0004435206,0.0003620422,0.006520434,0.0001962612,0.07153904,0.3358612,0.0001859517],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001851309,0.990005,0.001501249,0.006442619,0.0004610253,0.00007840976,0.0002975306,0.00002121151,0.001007933],"genre_scores_gemma":[0.006543155,0.9840306,0.005370196,0.002795113,0.0004596043,0.0003086997,0.0003115784,0.00002486458,0.0001561349],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9614829,"threshold_uncertainty_score":0.2037005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200326001","doi":"10.36469/jheor.2021.29145","title":"Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data","year":2021,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"London Health Sciences Centre; Sunnybrook Hospital; AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Stage (stratigraphy); Cancer; Disease; Internal medicine; Cohort study; Ovarian cancer","authors":[{"name":"M. Hurry","is_ca":true},{"name":"Shazia Hassan","is_ca":true},{"name":"Soo Jin Seung","is_ca":true},{"name":"R. Walton","is_ca":true},{"name":"Ashlie Elnoursi","is_ca":true},{"name":"Jacob McGee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2209768286796905,"gpt":0.4915679570257415,"spread":0.270591128346051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001272549,0.0004258117,0.0005652797,0.002797547,0.002600135,0.001545278,0.00146237,0.0004439168,0.001740624],"category_scores_gemma":[0.005129851,0.0006591119,0.0011407,0.01007752,0.0006901113,0.0005416398,0.00127902,0.0007879302,0.0002498359],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03589708,"about_ca_system_score_gemma":0.04096666,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9923335,"about_ca_topic_score_gemma":0.9938922,"domain_scores_codex":[0.9980552,0.0001396996,0.0002222469,0.0003002241,0.0007671234,0.0005154432],"domain_scores_gemma":[0.9943874,0.0003000113,0.001805358,0.0003918393,0.002428326,0.000686964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004744165,0.00001829281,0.996989,0.00004702333,0.00008806428,0.00004837767,0.0002442242,0.0001377758,0.0000412422,0.0000751109,0.001236106,0.001027354],"study_design_scores_gemma":[0.0000116917,0.00001583674,0.9970489,0.00006015999,0.00005750802,0.00007676885,0.0007229844,0.0006067941,0.00003481979,0.00003258155,0.001319386,0.00001246521],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9516864,0.0007570125,0.000291356,0.0003878218,0.00001453757,0.0002077695,0.04479296,0.00002000232,0.001842255],"genre_scores_gemma":[0.9838113,0.0005995801,0.0005448469,0.0001273228,0.000007379244,0.0001256405,0.01421924,0.0000103082,0.000554434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9641029,"threshold_uncertainty_score":0.2604527,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3160231534","doi":"10.36469/jheor.2021.22978","title":"Determinants of COVID-19 Case Fatality Rate in the US: Spatial Analysis Over One Year of the Pandemic","year":2021,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Case fatality rate; Pandemic; Demography; Coronavirus disease 2019 (COVID-19); Index (typography); Geography; Medicine; Environmental health; Disease; Population; Infectious disease (medical specialty); Sociology","authors":[{"name":"Niranjan Kathe","is_ca":false},{"name":"Rajvi Wani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1925171522508727,"gpt":0.5136866145523198,"spread":0.3211694623014471,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001580068,0.0002602085,0.000270176,0.001287043,0.0004551721,0.0007870559,0.0006605752,0.0004077763,0.002055714],"category_scores_gemma":[0.006932897,0.0002080028,0.001104157,0.002103643,0.0003595542,0.0007748595,0.001052646,0.0006827693,0.0002339966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001128583,"about_ca_system_score_gemma":0.001282221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1714658,"about_ca_topic_score_gemma":0.1195317,"domain_scores_codex":[0.9993661,0.0002152882,0.00005446075,0.0001597028,0.00008977929,0.0001146351],"domain_scores_gemma":[0.9967423,0.0009412863,0.001051743,0.0003018049,0.000653936,0.0003089697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003428848,0.00002516499,0.9956859,0.00001036103,0.0000755772,0.00003580106,0.0001300091,0.001460993,0.0000382958,0.00009962281,0.0005077418,0.001896291],"study_design_scores_gemma":[0.000003261878,0.00003853909,0.9906937,0.00001718559,0.00004183745,0.00007863894,0.001046172,0.00726632,0.00003398352,0.0002066177,0.0005643886,0.000009365373],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953238,0.00027159,0.0006396655,0.0004057624,0.00001068771,0.00002013133,0.002578974,0.00001991437,0.0007295255],"genre_scores_gemma":[0.9980175,0.0001132507,0.000227847,0.00002827106,0.000005512429,0.00001388355,0.00144194,0.00000472428,0.0001471027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1714658,"threshold_uncertainty_score":0.3409355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2976858013","doi":"10.36469/9682","title":"The Burden of Hypoxic Respiratory Failure in Preterm and Term/Near-term Infants in the United States 2011-2015","year":2019,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Respiratory distress; Neonatal intensive care unit; Pediatrics; Odds ratio; Respiratory failure; Anesthesia; Internal medicine","authors":[{"name":"Shivani Pandya","is_ca":false},{"name":"Onur Başer","is_ca":false},{"name":"George J. Wan","is_ca":false},{"name":"Belinda Lovelace","is_ca":false},{"name":"Jim Potenziano","is_ca":false},{"name":"An T. Pham","is_ca":false},{"name":"Xingyue Huang","is_ca":false},{"name":"Li Wang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07789917381528427,"gpt":0.4370342213191848,"spread":0.3591350475039005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006573867,0.0002241132,0.0002131912,0.0009096781,0.0002855642,0.0005191309,0.0005024871,0.0002586177,0.0007492208],"category_scores_gemma":[0.001873404,0.0001931354,0.0004879643,0.0009904461,0.000203237,0.0004361733,0.0009739097,0.0004833671,0.0001070745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001103171,"about_ca_system_score_gemma":0.0009347582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04341822,"about_ca_topic_score_gemma":0.05357221,"domain_scores_codex":[0.9994389,0.0001018063,0.0001283241,0.0001125365,0.0001275702,0.00009080332],"domain_scores_gemma":[0.998637,0.00009839197,0.0008105905,0.00004466052,0.0002161314,0.0001930788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001643383,0.00001011727,0.9975465,0.00002710289,0.00005799639,0.00005503308,0.00004207686,0.0001008892,0.00005820684,0.00003547893,0.0004229744,0.0016272],"study_design_scores_gemma":[9.968892e-7,0.0000188611,0.9990281,0.00002911099,0.00002173636,0.0001606988,0.0001799032,0.0002245668,0.00003295946,0.00001162867,0.0002891938,0.000002245038],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992558,0.001556783,0.0001271758,0.0002912858,0.00002284226,0.00001096864,0.004776592,0.000008432951,0.0006479411],"genre_scores_gemma":[0.995703,0.0009433505,0.0001204879,0.00007788211,0.00002748016,0.00001141669,0.002969357,0.000001775146,0.0001452157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04341822,"threshold_uncertainty_score":0.08633101,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981105730","doi":"10.36469/9841","title":"Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Government of Canada; University of Alberta","funders":"Health Canada; Astellas Pharma","keywords":"Discontinuation; Medicine; Overactive bladder; Medical prescription; Proportional hazards model; Internal medicine; Polypharmacy; Hazard ratio; Univariate analysis; Retrospective cohort study; Multivariate analysis; Emergency medicine; Pharmacology; Confidence interval; Alternative medicine","authors":[{"name":"Adrian Wagg","is_ca":true},{"name":"Demitri Diles","is_ca":true},{"name":"Todd Berner","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2118079820661007,"gpt":0.4924944205229027,"spread":0.280686438456802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005136886,0.0006257867,0.0009836584,0.009475118,0.002034152,0.00194113,0.001565433,0.000579567,0.001911938],"category_scores_gemma":[0.01496064,0.0006708231,0.002338779,0.01976443,0.0007553959,0.0006635205,0.001431088,0.0008870668,0.000254667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01799313,"about_ca_system_score_gemma":0.02302177,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9397674,"about_ca_topic_score_gemma":0.883793,"domain_scores_codex":[0.9940667,0.0005668422,0.0009092389,0.0008787934,0.0028271,0.0007512884],"domain_scores_gemma":[0.9825271,0.002649155,0.007366862,0.001136589,0.005130945,0.001189277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001155661,0.00001531237,0.9970058,0.00006650971,0.0001900993,0.00004051008,0.0001569505,0.0001558558,0.00003510432,0.00004045822,0.0004963818,0.001681485],"study_design_scores_gemma":[0.00001262205,0.00003844381,0.99762,0.00003877971,0.0001127337,0.000100641,0.0002806004,0.000951327,0.00003623495,0.00002221762,0.0007675118,0.00001885216],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9575515,0.001847219,0.0006976803,0.0002519402,0.00001463355,0.0003070254,0.0378607,0.00005332097,0.001416029],"genre_scores_gemma":[0.983165,0.0009072688,0.0007941304,0.00007021439,0.00001051094,0.0001397474,0.01467604,0.00001620086,0.0002208441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06023264,"threshold_uncertainty_score":0.13055,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323064029","doi":"10.36469/jheor.2023.68191","title":"Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States","year":2023,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"GERD; Medicine; Cohort; Dysplasia; Esophagus; Barrett's esophagus; Internal medicine; Disease; Gastroenterology; Health care; Reflux; Adenocarcinoma; Cancer","authors":[{"name":"Prateek Sharma","is_ca":false},{"name":"Gary W. Falk","is_ca":false},{"name":"Menaka Bhor","is_ca":false},{"name":"A. Burak Ozbay","is_ca":false},{"name":"Dominick Latrémouille-Viau","is_ca":true},{"name":"Annie Guérin","is_ca":true},{"name":"Sherry Shi","is_ca":true},{"name":"Margaret Elvekrog","is_ca":false},{"name":"Paul J. Limburg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0475957058017199,"gpt":0.3743526500852333,"spread":0.3267569442835134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004191084,0.0002296258,0.0002616175,0.001083642,0.0003516346,0.000641987,0.0003157038,0.000327412,0.001197852],"category_scores_gemma":[0.001960729,0.0001745155,0.000569581,0.00201272,0.0002273787,0.0004969569,0.0005951906,0.0005205974,0.0001235337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001200913,"about_ca_system_score_gemma":0.0007797995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0311731,"about_ca_topic_score_gemma":0.03610044,"domain_scores_codex":[0.99939,0.0001582102,0.000132677,0.00008050182,0.0001262866,0.0001123209],"domain_scores_gemma":[0.9986799,0.0001463391,0.000784972,0.00003214833,0.0001110827,0.0002454393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003690524,0.00003529181,0.9976446,0.00001697656,0.0000812011,0.00005135428,0.0000273755,0.000186954,0.00002472939,0.00004870438,0.0006042438,0.001241658],"study_design_scores_gemma":[0.000008348989,0.00004310426,0.9983656,0.00002952136,0.00003711959,0.0001708371,0.0002020933,0.0006915116,0.00002136605,0.00005231866,0.0003739822,0.000004180652],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940624,0.001021624,0.00004498627,0.0004057588,0.00001464825,0.00001395222,0.003484548,0.000004808981,0.0009472138],"genre_scores_gemma":[0.9971048,0.0003732977,0.0000706338,0.0001363309,0.00001875131,0.0000149432,0.002194256,0.000001131423,0.00008578398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0311731,"threshold_uncertainty_score":0.06198335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3071800551","doi":"10.36469/jheor.2020.13687","title":"Sternal-Wound Infections following Coronary Artery Bypass Graft: Could Implementing Value-Based Purchasing be Beneficial?","year":2020,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Surgical site infection prevention","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Purchasing; Health care; Intervention (counseling); Total cost; Mortality rate; Emergency medicine; Environmental health; Business; Surgery; Operations management; Economic growth; Economics; Nursing","authors":[{"name":"Dominique Brandt","is_ca":false},{"name":"Maximilian Maximilian","is_ca":false},{"name":"Julie Lankiewicz","is_ca":false},{"name":"Peter J. Mallow","is_ca":false},{"name":"Rhodri Saunders","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1298397076687202,"gpt":0.4421791064719029,"spread":0.3123393988031828,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009688304,0.0003217977,0.0004796441,0.0006004757,0.0002751915,0.002690127,0.0006890525,0.0008053109,0.002250634],"category_scores_gemma":[0.02722733,0.0002468708,0.001044731,0.00113022,0.0007836762,0.001924122,0.0008970081,0.0009683832,0.000107403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00304997,"about_ca_system_score_gemma":0.004701189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005352113,"about_ca_topic_score_gemma":0.008610479,"domain_scores_codex":[0.9947465,0.004174662,0.0001939036,0.0001657067,0.0003672905,0.0003519693],"domain_scores_gemma":[0.9792807,0.01565729,0.003007482,0.0002765897,0.00132286,0.0004551203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.001502503,0.001013952,0.3223375,0.00975658,0.001827244,0.0008987169,0.001732645,0.1654963,0.001072416,0.05296931,0.004889301,0.4365035],"study_design_scores_gemma":[0.001072818,0.005589932,0.3231833,0.0317065,0.003738735,0.001417207,0.01491016,0.3726767,0.004662365,0.2014919,0.03925818,0.0002922271],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8886274,0.02899125,0.02443798,0.03485827,0.0002034946,0.0007016502,0.000921034,0.00004489544,0.02121408],"genre_scores_gemma":[0.987157,0.005315296,0.006573544,0.0006075723,0.00003692959,0.00009043796,0.0001017298,0.000004200771,0.000113259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009688304,"threshold_uncertainty_score":0.05123723,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323038398","doi":"10.36469/001c.68191","title":"Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States","year":2023,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"GERD; Medicine; Cohort; Dysplasia; Barrett's esophagus; Esophagus; Internal medicine; Disease; Gastroenterology; Health care; Reflux; Adenocarcinoma; Cancer","authors":[{"name":"Prateek Sharma","is_ca":false},{"name":"Gary W. Falk","is_ca":false},{"name":"Menaka Bhor","is_ca":false},{"name":"A. Burak Ozbay","is_ca":false},{"name":"Dominick Latrémouille-Viau","is_ca":true},{"name":"Annie Guérin","is_ca":true},{"name":"Sherry Shi","is_ca":true},{"name":"Margaret Elvekrog","is_ca":false},{"name":"Paul J. Limburg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0475957058017199,"gpt":0.3743526500852333,"spread":0.3267569442835134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003745297,0.000228712,0.0002791343,0.001167959,0.0003453548,0.0006861109,0.0003004622,0.0003109106,0.001263962],"category_scores_gemma":[0.001995761,0.0001602393,0.0006038161,0.002192045,0.0002312389,0.0004985012,0.0006201953,0.0004803893,0.0001163653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001229166,"about_ca_system_score_gemma":0.0007850186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03306673,"about_ca_topic_score_gemma":0.03703695,"domain_scores_codex":[0.9993588,0.0001597228,0.0001405429,0.00008941208,0.0001240133,0.0001274958],"domain_scores_gemma":[0.9987068,0.0001456025,0.0007460159,0.00002926634,0.000107429,0.0002649131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003537854,0.00003665982,0.997241,0.00002023698,0.00008534206,0.00005577394,0.00002753592,0.0002236247,0.0000253779,0.00006357289,0.0006651024,0.001520285],"study_design_scores_gemma":[0.000008790171,0.0000447242,0.99814,0.00003359186,0.00004152058,0.0001830762,0.0002167572,0.0007818523,0.00002349394,0.00006712252,0.0004542621,0.000004773585],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927453,0.001331257,0.00005197643,0.0004603351,0.00001837795,0.00001672323,0.004256383,0.000005458448,0.001114237],"genre_scores_gemma":[0.9967813,0.0004752897,0.0000807791,0.0001545126,0.00002476003,0.00001770293,0.002373255,0.00000118296,0.00009126092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03306673,"threshold_uncertainty_score":0.06574857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214849882","doi":"10.36469/jheor.2022.31825","title":"Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States","year":2022,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Tenofovir alafenamide; Medicine; Body mass index; Regimen; Weight change; Internal medicine; Weight loss; Human immunodeficiency virus (HIV); Obesity; Viral load; Antiretroviral therapy; Immunology","authors":[{"name":"Bruno Émond","is_ca":true},{"name":"Carmine Rossi","is_ca":true},{"name":"Rachel Rogers","is_ca":false},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Prina Donga","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0382161477841703,"gpt":0.3711196666282715,"spread":0.3329035188441012,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002134599,0.0002800539,0.0003602164,0.0009227475,0.000305609,0.0006438847,0.000443379,0.0004685127,0.000896086],"category_scores_gemma":[0.005730203,0.0003138958,0.0007050793,0.001743501,0.0003124085,0.0006065481,0.0005788096,0.0005953826,0.0001989068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006829464,"about_ca_system_score_gemma":0.0004497302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009969921,"about_ca_topic_score_gemma":0.01023531,"domain_scores_codex":[0.9984576,0.0007928874,0.0001926534,0.0002981736,0.0001531024,0.0001056003],"domain_scores_gemma":[0.9948695,0.001270941,0.002798909,0.0004230451,0.0003180683,0.0003196002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002735056,0.00006190238,0.9980107,0.00002209948,0.0001768433,0.00003893359,0.00004182948,0.0002547926,0.00004744052,0.00002596474,0.0002652032,0.000780797],"study_design_scores_gemma":[0.0000493975,0.0003496208,0.9941092,0.00002995602,0.0001294825,0.0002369462,0.000350167,0.004065144,0.00008807922,0.00006552974,0.0005119307,0.00001458428],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966067,0.0001958451,0.0001351483,0.00006878306,0.000008122821,0.00001597365,0.00282371,0.000004701208,0.0001411444],"genre_scores_gemma":[0.9958222,0.0001258029,0.000350383,0.00004853425,0.00001171942,0.00004062488,0.003535642,0.000001708866,0.0000634497],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009969921,"threshold_uncertainty_score":0.01982379,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125064772","doi":"10.36469/jheor.2021.18727","title":"A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms","year":2021,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Adrenocorticotropic hormone; Medicine; Psychology; Hormone; Internal medicine","authors":[{"name":"Michael Duchowny","is_ca":false},{"name":"Ishveen Chopra","is_ca":false},{"name":"John Niewoehner","is_ca":false},{"name":"George J. Wan","is_ca":false},{"name":"Beth Devine","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06527118050900231,"gpt":0.425321204746247,"spread":0.3600500242372447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01134927,0.002079407,0.01692523,0.010186,0.0007853976,0.003061866,0.002368791,0.002537228,0.009956074],"category_scores_gemma":[0.03778228,0.001049105,0.01497329,0.008533402,0.00120725,0.002650197,0.001530854,0.001661861,0.0004929338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005456337,"about_ca_system_score_gemma":0.008945463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006291207,"about_ca_topic_score_gemma":0.01540039,"domain_scores_codex":[0.9848948,0.006870809,0.005010471,0.001080298,0.001804338,0.0003393759],"domain_scores_gemma":[0.9725764,0.02037389,0.004597732,0.0003340013,0.001780761,0.0003372227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001512198,0.00002603311,0.0004613915,0.944461,0.04018568,0.0000745392,0.00009683621,0.0001227761,0.0001617331,0.0001733062,0.0004318765,0.01229269],"study_design_scores_gemma":[0.004393628,0.001142453,0.003810967,0.509235,0.471908,0.0002935073,0.0002739342,0.0002390696,0.0002413165,0.0004525809,0.007945702,0.00006382877],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004586828,0.9905434,0.0004414962,0.0002618507,0.0002194969,0.002076696,0.001068015,0.00002517777,0.0007769782],"genre_scores_gemma":[0.09229739,0.8957322,0.002567929,0.001316146,0.0002617042,0.006319005,0.0008999812,0.00002332168,0.0005823552],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01692523,"threshold_uncertainty_score":0.0600214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981126019","doi":"10.36469/9837","title":"Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Southlake Regional Health Center","funders":"Biosense Webster","keywords":"Medicine; Atrial fibrillation; Cost effectiveness; Quality-adjusted life year; Cohort; Catheter ablation; Cost-effectiveness analysis; Confidence interval; Cost–benefit analysis; Emergency medicine; Internal medicine; Demography","authors":[{"name":"Yaariv Khaykin","is_ca":true},{"name":"Peter J. Mallow","is_ca":false},{"name":"John A. Rizzo","is_ca":false},{"name":"Atul Verma","is_ca":true},{"name":"Lauren Chun","is_ca":true},{"name":"Shelby Olesovsky","is_ca":true},{"name":"Matthew R. Reynolds","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2215460952908969,"gpt":0.4773155426121317,"spread":0.2557694473212348,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002098589,0.0008918496,0.0008099222,0.00241555,0.001279494,0.003019465,0.001300943,0.001465147,0.005607696],"category_scores_gemma":[0.00952761,0.0003501389,0.001865402,0.003120675,0.0007700418,0.0008430841,0.0006723297,0.001346049,0.0002021578],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07999517,"about_ca_system_score_gemma":0.07980183,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9603627,"about_ca_topic_score_gemma":0.9555133,"domain_scores_codex":[0.9977196,0.0008063255,0.00008609183,0.0001580969,0.0007884993,0.0004413435],"domain_scores_gemma":[0.997242,0.0009880244,0.0002224592,0.00003187096,0.001147986,0.000367619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.002259947,0.0002753767,0.05102174,0.002090434,0.002645905,0.0007936038,0.0004621964,0.6436388,0.001066483,0.1261431,0.04813181,0.1214706],"study_design_scores_gemma":[0.001697092,0.0007910079,0.1035539,0.002982242,0.004642025,0.001162168,0.001948712,0.7494483,0.0009526038,0.04557505,0.08667281,0.000574122],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4401121,0.1104006,0.02024077,0.1030969,0.001067747,0.0009752791,0.03813547,0.0001798833,0.2857913],"genre_scores_gemma":[0.9699518,0.01735722,0.005445358,0.001392224,0.0001308321,0.00008941844,0.002579356,0.00002783971,0.003026001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9200048,"threshold_uncertainty_score":0.5804083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2580974718","doi":"10.36469/9818","title":"What Drives Responses to Willingness-to-pay Questions? A Methodological Inquiry in the Context of Hypertension Self-management","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Descriptive statistics; Willingness to pay; Actuarial science; Valuation (finance); Test (biology); Context (archaeology); Psychological intervention; Multivariate statistics; Contingent valuation; Medicine; Psychology; Statistics; Economics; Nursing; Accounting; Mathematics","authors":[{"name":"Billingsley Kaambwa","is_ca":false},{"name":"Stirling Bryan","is_ca":true},{"name":"Emma Frew","is_ca":false},{"name":"Emma P Bray","is_ca":false},{"name":"Sheila Greenfield","is_ca":false},{"name":"Richard J. McManus","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7052211355047316,"gpt":0.5771883943140663,"spread":0.1280327411906653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3867404,0.0005379128,0.001431966,0.00445459,0.003073409,0.009699257,0.002862629,0.003611642,0.004599506],"category_scores_gemma":[0.6539454,0.000925537,0.002600549,0.005264399,0.009222684,0.006589076,0.004369935,0.003012433,0.0003920231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007263665,"about_ca_system_score_gemma":0.007351019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003659695,"about_ca_topic_score_gemma":0.002917654,"domain_scores_codex":[0.450988,0.505342,0.01759256,0.008756233,0.01357603,0.003745127],"domain_scores_gemma":[0.2304935,0.7190281,0.02858453,0.00929428,0.01132862,0.001270907],"domain_codex":"methods","domain_gemma":"methods","domain_candidate":"methods","domain_consensus":"methods","study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001167992,0.001394535,0.4379271,0.006311432,0.001859637,0.000591034,0.3507267,0.002113315,0.0007409485,0.05816357,0.002642262,0.1363615],"study_design_scores_gemma":[0.0006499117,0.002445659,0.3427713,0.007063783,0.001084332,0.0009772417,0.4762855,0.02100483,0.001387578,0.1278046,0.01813464,0.0003907498],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9000919,0.002930053,0.06011847,0.01873878,0.0002703879,0.004554618,0.0004095597,0.00003736622,0.01284877],"genre_scores_gemma":[0.98013,0.0003346682,0.01405814,0.001735385,0.00005132739,0.003303617,0.0000855967,0.00001832726,0.0002829518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6132597,"threshold_uncertainty_score":0.7562584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403810575","doi":"10.36469/001c.124208","title":"Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Bladder cancer; Context (archaeology); Maintenance therapy; Carcinoma in situ; Internal medicine; Guideline; Oncology; Cancer; Urology; Surgery; Chemotherapy; Pathology","authors":[{"name":"Franklin Gaylis","is_ca":false},{"name":"Bruno Émond","is_ca":true},{"name":"Ameur M. Manceur","is_ca":true},{"name":"Anabelle Tardif‐Samson","is_ca":true},{"name":"Laura Morrison","is_ca":true},{"name":"Dominic Pilon","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Lorie Ellis","is_ca":false},{"name":"Balaji Hiremagalur","is_ca":false},{"name":"Andrea Ireland","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09136423934102175,"gpt":0.4284052855017772,"spread":0.3370410461607555,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002089954,0.00008376424,0.0003262671,0.0006239013,0.0002712201,0.000564396,0.0003899355,0.0004095355,0.0007830902],"category_scores_gemma":[0.01881448,0.00009362377,0.0003938807,0.001408625,0.0001228733,0.0003447917,0.0003296973,0.0006333442,0.00007793938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008436699,"about_ca_system_score_gemma":0.001695247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02013092,"about_ca_topic_score_gemma":0.0314848,"domain_scores_codex":[0.9974777,0.001028194,0.0005611751,0.0002198662,0.0005253042,0.0001878153],"domain_scores_gemma":[0.9913372,0.002338102,0.004647743,0.0002099655,0.0009263261,0.0005407133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000117878,0.0001163051,0.9735895,0.0001042861,0.0001050584,0.00005039993,0.0002025633,0.0002279525,0.00006511179,0.00007416474,0.00276503,0.02258176],"study_design_scores_gemma":[0.00004793841,0.0001887727,0.9938008,0.0002614608,0.00009430118,0.0001697708,0.0004868419,0.002077245,0.0001412768,0.0001103697,0.002612324,0.000008977131],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839828,0.003879914,0.0006433356,0.004635537,0.00008979382,0.0001494827,0.002223019,0.00003659781,0.004359456],"genre_scores_gemma":[0.9970062,0.000647789,0.0006635601,0.0005580669,0.00003640459,0.00006163472,0.0008898455,0.000004443679,0.0001320885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02013092,"threshold_uncertainty_score":0.0400275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975211644","doi":"10.36469/9744","title":"Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism","year":2019,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Medicine; Pulmonary embolism; Confidence interval; Odds ratio; Pulmonary angiography; Internal medicine; Logistic regression; Cardiology","authors":[{"name":"Li Wang","is_ca":false},{"name":"Onur Başer","is_ca":false},{"name":"Philip S. Wells","is_ca":true},{"name":"W. Frank Peacock","is_ca":false},{"name":"Craig I Coleman","is_ca":false},{"name":"Gregory J. Fermann","is_ca":false},{"name":"Jeff Schein","is_ca":false},{"name":"Concetta Crivera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01216100580515167,"gpt":0.305075553548598,"spread":0.2929145477434463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003832207,0.0001941317,0.0001924048,0.000432554,0.0002055955,0.0005010923,0.000279404,0.000301145,0.001674014],"category_scores_gemma":[0.003143611,0.0001098412,0.0002441518,0.0005517356,0.0001499649,0.0003153259,0.0003241783,0.0006127333,0.0001543532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002822135,"about_ca_system_score_gemma":0.0003535956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003199433,"about_ca_topic_score_gemma":0.004200137,"domain_scores_codex":[0.9997405,0.00006278079,0.00004441058,0.0000395782,0.00005378812,0.00005890817],"domain_scores_gemma":[0.9974674,0.0004408824,0.001454565,0.0000511748,0.000203611,0.0003823307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002161937,0.000007021935,0.9996173,0.000002832395,0.000007988434,0.00001333353,0.000006221137,0.00002155483,0.00002012871,0.000004358028,0.00003798622,0.0002396821],"study_design_scores_gemma":[0.000003100634,0.00004411509,0.999323,0.000007639713,0.00001055217,0.0001526293,0.0000655177,0.0002945439,0.00002010464,0.00002095977,0.00005616556,0.000001758178],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992581,0.000238859,0.00004810714,0.00008773291,0.000004369981,0.000002769796,0.0002005839,0.000002117013,0.0001571836],"genre_scores_gemma":[0.999645,0.00005405283,0.0000343339,0.00001283057,0.00000731968,0.000002059038,0.000210546,5.627314e-7,0.00003338719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003199433,"threshold_uncertainty_score":0.006361604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4289856656","doi":"10.36469/jheor.2022.36976","title":"Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective","year":2022,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Discontinuation; Dasatinib; Nilotinib; Internal medicine; Myeloid leukemia; Imatinib; Bosutinib; Pediatrics","authors":[{"name":"Ehab Atallah","is_ca":false},{"name":"Rodrigo Maegawa","is_ca":false},{"name":"Dominick Latrémouille-Viau","is_ca":true},{"name":"Carmine Rossi","is_ca":true},{"name":"Annie Guérin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06831243107343316,"gpt":0.4248905147898626,"spread":0.3565780837164295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007513547,0.0003521988,0.0003155208,0.00130595,0.0003166814,0.001295191,0.0004429923,0.0005908422,0.002988676],"category_scores_gemma":[0.002582252,0.0002367682,0.00104079,0.003996179,0.0002517245,0.000902202,0.0007855581,0.0009851758,0.0001703291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003793727,"about_ca_system_score_gemma":0.001515709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05282079,"about_ca_topic_score_gemma":0.05261017,"domain_scores_codex":[0.9991829,0.0002361931,0.0001263223,0.0001061033,0.0001897081,0.0001587325],"domain_scores_gemma":[0.9978883,0.0002263337,0.001402831,0.00003356293,0.000180356,0.0002686357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001387264,0.0001004009,0.975455,0.0001586678,0.0003543724,0.0000948541,0.0001176128,0.001505245,0.00007959441,0.001095068,0.01130468,0.009595794],"study_design_scores_gemma":[0.00002469436,0.00006308716,0.9914581,0.0001978459,0.00009867434,0.0002401843,0.0005698921,0.002739262,0.00004765204,0.0003300501,0.004219878,0.00001061382],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9374285,0.01168118,0.0003267872,0.009340159,0.0001514742,0.0001192196,0.03633361,0.00001398259,0.004605132],"genre_scores_gemma":[0.9817564,0.004046203,0.0002645842,0.0009269185,0.0001690728,0.0001005932,0.01226538,0.00000510918,0.0004656565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05282079,"threshold_uncertainty_score":0.1050267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4289856100","doi":"10.36469/001c.36975","title":"Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States","year":2022,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation; International Business Machines Corporation","keywords":"Medicine; Health care; Myeloid leukemia; Pharmacy; Population; Incidence (geometry); Emergency medicine; Internal medicine; Family medicine; Environmental health","authors":[{"name":"Ehab Atallah","is_ca":false},{"name":"Rodrigo Maegawa","is_ca":false},{"name":"Dominick Latrémouille-Viau","is_ca":true},{"name":"Carmine Rossi","is_ca":true},{"name":"Annie Guérin","is_ca":true},{"name":"Eric Q. Wu","is_ca":false},{"name":"Pallavi Patwardhan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1146702665762677,"gpt":0.4133945182437246,"spread":0.298724251667457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007399085,0.0002407016,0.0002852021,0.001362606,0.0002852285,0.001131569,0.0003045729,0.000411181,0.001818955],"category_scores_gemma":[0.002310337,0.0002110714,0.0005874179,0.00433489,0.0002482242,0.0007846562,0.0006941113,0.00055747,0.000257471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001461689,"about_ca_system_score_gemma":0.0006624244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02708502,"about_ca_topic_score_gemma":0.02693811,"domain_scores_codex":[0.9992107,0.0001691566,0.0002108412,0.0001609176,0.0001407557,0.0001075082],"domain_scores_gemma":[0.9972408,0.0002327129,0.002055943,0.00006438645,0.0001730663,0.0002331417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005201638,0.0000291774,0.9950046,0.0000445974,0.00009339841,0.00003041517,0.00005631316,0.0001732047,0.00004622251,0.00009321084,0.00161333,0.002763464],"study_design_scores_gemma":[0.000005701144,0.00002183326,0.9978992,0.00004628533,0.00001937693,0.0001421445,0.0002548426,0.0004425131,0.00002420941,0.00006144917,0.001077761,0.000004773507],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665247,0.003824476,0.000152041,0.001106572,0.00002582057,0.00004078853,0.02701856,0.00001266212,0.001294411],"genre_scores_gemma":[0.9822586,0.001629889,0.0002266331,0.0002908213,0.00005048393,0.00006370451,0.01529098,0.000004039406,0.000184859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02708502,"threshold_uncertainty_score":0.0538547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2979536446","doi":"10.36469/9936","title":"Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care","year":2019,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Janssen Research and Development; Bayer","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Propensity score matching; Warfarin; Low molecular weight heparin; Anticoagulant; Internal medicine; Emergency medicine; Heparin; Atrial fibrillation","authors":[{"name":"W. Frank Peacock","is_ca":false},{"name":"Craig I Coleman","is_ca":false},{"name":"Philip S. Wells","is_ca":true},{"name":"Gregory J. Fermann","is_ca":false},{"name":"Li Wang","is_ca":false},{"name":"Onur Başer","is_ca":false},{"name":"Jeff Schein","is_ca":false},{"name":"Concetta Crivera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03723291568705323,"gpt":0.4002287013889841,"spread":0.3629957857019309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001451127,0.0002141404,0.0006414763,0.0006696577,0.0003352165,0.0009130529,0.0003859427,0.0004426263,0.001183813],"category_scores_gemma":[0.006709604,0.0001254358,0.001049828,0.0007781279,0.0003655304,0.0004895957,0.0006677398,0.0005258634,0.00008630043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001496056,"about_ca_system_score_gemma":0.0007593922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003308562,"about_ca_topic_score_gemma":0.003226446,"domain_scores_codex":[0.9985774,0.0006424917,0.0001741923,0.0002000777,0.0001762695,0.0002296358],"domain_scores_gemma":[0.9972446,0.0005952028,0.001336049,0.00007116987,0.0001592629,0.0005936302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01073088,0.0008747364,0.9758778,0.0001152055,0.001133728,0.0001084858,0.00009058772,0.000984968,0.0001702314,0.0002049185,0.0006549583,0.009053573],"study_design_scores_gemma":[0.001512556,0.005146621,0.9883859,0.00005743373,0.0004948083,0.0002184412,0.0002643191,0.00310349,0.0001384807,0.0003219331,0.0003379046,0.00001821301],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988713,0.0004752216,0.00003262893,0.0001480265,0.000009775209,0.00002074425,0.0001943563,8.698302e-7,0.0002470769],"genre_scores_gemma":[0.9994028,0.0001011921,0.00003276604,0.00005147232,0.0000148038,0.00001667009,0.0003560339,3.309762e-7,0.00002405824],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003308562,"threshold_uncertainty_score":0.01085472,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2980909881","doi":"10.36469/9838","title":"The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pfizer (Canada); Université de Sherbrooke","funders":"","keywords":"Reimbursement; Incentive; Health technology; Compromise; Context (archaeology); Order (exchange); Risk analysis (engineering); Business; Actuarial science; Public economics; Medicine; Health care; Economics; Finance; Economic growth; Microeconomics; Political science","authors":[{"name":"Pierre-Alexandre Dionne","is_ca":true},{"name":"Mendel Grobler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4265158938132272,"gpt":0.5987527391384256,"spread":0.1722368453251985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01615305,0.001359513,0.001452744,0.003910066,0.001716256,0.008276164,0.003039569,0.007149267,0.0135632],"category_scores_gemma":[0.04663346,0.0007841917,0.001882112,0.002142796,0.01284107,0.01191888,0.003769007,0.004582639,0.001127169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005983293,"about_ca_system_score_gemma":0.004668031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001684418,"about_ca_topic_score_gemma":0.001376059,"domain_scores_codex":[0.9907177,0.004739209,0.0003593509,0.001533934,0.001982556,0.0006671275],"domain_scores_gemma":[0.9589587,0.03195747,0.003551507,0.003029377,0.001990345,0.0005125742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.00002073966,0.00002956473,0.0004241656,0.00009179324,0.00001440594,0.00007266535,0.00008070929,0.005381797,0.0001762841,0.9837964,0.001168964,0.008742624],"study_design_scores_gemma":[0.00004239274,0.000105837,0.000717032,0.0001243209,0.00004809393,0.0001839979,0.0001140446,0.03237396,0.0005396724,0.953486,0.01220885,0.00005582145],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.02238994,0.004928997,0.7559285,0.03702902,0.0009291515,0.000763828,0.000533637,0.0005028109,0.1769941],"genre_scores_gemma":[0.8402758,0.004335677,0.1342567,0.003422526,0.00132998,0.001210463,0.0001008356,0.0001769836,0.01489105],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.01615305,"threshold_uncertainty_score":0.08542651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4289815058","doi":"10.36469/001c.36976","title":"Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective","year":2022,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Myeloid leukemia; Perspective (graphical); Medicine; Phase (matter); Intensive care medicine; Internal medicine; Chemistry; Computer science; Artificial intelligence","authors":[{"name":"Ehab Atallah","is_ca":false},{"name":"Rodrigo Maegawa","is_ca":false},{"name":"Dominick Latrémouille-Viau","is_ca":true},{"name":"Carmine Rossi","is_ca":true},{"name":"Annie Guérin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06831243107343316,"gpt":0.4248905147898626,"spread":0.3565780837164295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006535106,0.0003331622,0.0002987897,0.001307655,0.000308709,0.001305882,0.000396797,0.0005339745,0.002958541],"category_scores_gemma":[0.002578636,0.0002195555,0.0009623056,0.003915197,0.000235013,0.0008603479,0.0007686049,0.0008982362,0.0001599597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003709543,"about_ca_system_score_gemma":0.001426392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0503214,"about_ca_topic_score_gemma":0.05267385,"domain_scores_codex":[0.9992096,0.0002300718,0.0001240155,0.0001004349,0.0001805563,0.0001552382],"domain_scores_gemma":[0.9980273,0.0002162284,0.001293526,0.00003033014,0.0001761886,0.0002564898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001404736,0.00009840592,0.9706156,0.0001821277,0.0003646752,0.0001027037,0.0001241197,0.001553136,0.00008969588,0.001433406,0.01244904,0.01284659],"study_design_scores_gemma":[0.00002460495,0.00006490999,0.99041,0.0002239646,0.0001050288,0.0002556188,0.0006168684,0.002687056,0.00005108627,0.0004082457,0.005141166,0.00001145208],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9265616,0.01577584,0.000403872,0.0113288,0.0001840436,0.0001341955,0.03990741,0.00001673798,0.005687529],"genre_scores_gemma":[0.9805781,0.00524418,0.0003178594,0.001074511,0.0002050855,0.0001102792,0.0119632,0.000005581868,0.0005013487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0503214,"threshold_uncertainty_score":0.100057,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4289793462","doi":"10.36469/jheor.2022.36975","title":"Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States","year":2022,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation; International Business Machines Corporation","keywords":"Medicine; Health care; Pharmacy; Myeloid leukemia; Population; Emergency medicine; Incidence (geometry); Internal medicine; Family medicine; Environmental health","authors":[{"name":"Ehab Atallah","is_ca":false},{"name":"Rodrigo Maegawa","is_ca":false},{"name":"Dominick Latrémouille-Viau","is_ca":true},{"name":"Carmine Rossi","is_ca":true},{"name":"Annie Guérin","is_ca":true},{"name":"Eric Q. Wu","is_ca":false},{"name":"Pallavi Patwardhan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1146702665762677,"gpt":0.4133945182437246,"spread":0.298724251667457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000792285,0.0002263642,0.0002830809,0.001159733,0.0002859754,0.001009438,0.0003168541,0.0004239563,0.001654496],"category_scores_gemma":[0.002127425,0.0002147939,0.0005510015,0.003708297,0.0002462925,0.0007332873,0.0006627303,0.0005539614,0.0002599115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001361786,"about_ca_system_score_gemma":0.0006582148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02670151,"about_ca_topic_score_gemma":0.02595117,"domain_scores_codex":[0.9992614,0.0001619333,0.0001884726,0.0001517543,0.0001378671,0.00009854331],"domain_scores_gemma":[0.997283,0.0002232846,0.002016242,0.00006920254,0.0001740847,0.0002342023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000556153,0.00002869023,0.9961481,0.0000321691,0.00007884028,0.00002779435,0.00005337597,0.0001419163,0.00004822232,0.00005584548,0.001260899,0.002068663],"study_design_scores_gemma":[0.000005597756,0.00002217742,0.9983503,0.00003364892,0.00001634174,0.0001281996,0.0002249885,0.0003759439,0.00002339148,0.00003714271,0.0007782992,0.000004067051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774789,0.002198654,0.0001075953,0.0007591255,0.0000165143,0.00003074116,0.01847685,0.000009888975,0.0009217017],"genre_scores_gemma":[0.9863122,0.001039495,0.0001656679,0.000228188,0.00003290738,0.00004963321,0.0120149,0.000003395173,0.0001535981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02670151,"threshold_uncertainty_score":0.05309218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401698523","doi":"10.36469/jheor.2024.121233","title":"Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting","year":2024,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Urology; Androgen deprivation therapy; Bicalutamide; Cohort; Oncology; Cancer; Androgen receptor","authors":[{"name":"Benjamin Lowentritt","is_ca":false},{"name":"Carmine Rossi","is_ca":true},{"name":"Erik Muser","is_ca":false},{"name":"Frédéric Kinkead","is_ca":true},{"name":"Bronwyn Moore","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Dominic Pilon","is_ca":true},{"name":"Shawn Du","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0954274413607885,"gpt":0.4685944567940695,"spread":0.373167015433281,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009459204,0.0001614082,0.0002658184,0.0009964249,0.0005478348,0.0006716977,0.0004244399,0.0003644146,0.0009641691],"category_scores_gemma":[0.003086137,0.0002365617,0.0003744221,0.00139354,0.0003704909,0.0006367008,0.0005610558,0.0005596437,0.0001404611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008086301,"about_ca_system_score_gemma":0.0007385992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01305312,"about_ca_topic_score_gemma":0.01814158,"domain_scores_codex":[0.9990164,0.0003093564,0.0001286123,0.0002135024,0.0001728921,0.0001591512],"domain_scores_gemma":[0.9948788,0.0005340892,0.003616949,0.0001572415,0.0002850316,0.0005280378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003121017,0.00001844557,0.9994279,0.000003737451,0.00002139393,0.00001735132,0.00005549136,0.00002049039,0.00002675851,0.000006695243,0.00004502192,0.0003255215],"study_design_scores_gemma":[0.000006074816,0.00008206197,0.99893,0.000007393195,0.00001556656,0.0001768792,0.0003979306,0.0001872869,0.00004032132,0.00001602026,0.0001356627,0.000004830511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991499,0.0001020229,0.0000372196,0.00005887416,0.000002203363,0.000006974148,0.000472618,0.000002120457,0.0001681605],"genre_scores_gemma":[0.9993825,0.00006109836,0.00005393027,0.00003179131,0.000005398633,0.00000862802,0.0004247849,9.87918e-7,0.00003095995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01305312,"threshold_uncertainty_score":0.02595431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981122903","doi":"10.36469/9824","title":"Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Knee replacement; Antithrombotic; Arthroplasty; Observational study; Hip replacement; Enoxaparin sodium; Low molecular weight heparin; Randomized controlled trial; Clinical trial; Thrombosis; Surgery; Anesthesia; Internal medicine; Atrial fibrillation; Warfarin","authors":[{"name":"Xavier Granero Xiberta","is_ca":false},{"name":"Antonio Murcia","is_ca":false},{"name":"José Ricardo Troncoso Durán","is_ca":false},{"name":"Claudio Gómez Zubeldia","is_ca":false},{"name":"Aleix Llorac Moix","is_ca":false},{"name":"Ruth Graefenhain de Codes","is_ca":false},{"name":"Maria Giovana Ferrario","is_ca":false},{"name":"Luís Lizán","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0769273760446206,"gpt":0.4442252861319987,"spread":0.3672979100873781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005396926,0.0007967337,0.000759844,0.002077914,0.000220893,0.002071018,0.0007327027,0.0009457055,0.002309083],"category_scores_gemma":[0.009079832,0.0003698757,0.001721348,0.00203561,0.0004044882,0.0007522764,0.001151408,0.0007951243,0.0001736365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01057803,"about_ca_system_score_gemma":0.006764258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05730135,"about_ca_topic_score_gemma":0.02346089,"domain_scores_codex":[0.9968899,0.00203155,0.0001555408,0.0001868348,0.0002925317,0.0004436035],"domain_scores_gemma":[0.9947096,0.002492515,0.001311822,0.0001637039,0.0006725398,0.0006496962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.016317,0.001584515,0.3172699,0.002131951,0.002613684,0.001230667,0.0001866976,0.5620273,0.0008602022,0.008642532,0.01085485,0.07628065],"study_design_scores_gemma":[0.009005597,0.006334477,0.5969841,0.002738815,0.00439071,0.001714672,0.002162089,0.3303422,0.001850324,0.00795554,0.03626448,0.0002570349],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9591222,0.01622638,0.003284595,0.003184738,0.0001560635,0.0003469853,0.008692561,0.00007038279,0.008915956],"genre_scores_gemma":[0.9926645,0.002616522,0.001057901,0.0002396208,0.00002763842,0.0001410312,0.002538049,0.00001139565,0.0007032891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05730135,"threshold_uncertainty_score":0.1139356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413824545","doi":"10.36469/001c.142771","title":"Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Osimertinib; Medicine; Lung cancer; Oncology; Internal medicine; non-small cell lung cancer (NSCLC); Immunotherapy; Chemotherapy; Health care; Epidermal growth factor receptor; Cancer; Erlotinib","authors":[{"name":"David Waterhouse","is_ca":false},{"name":"I. А. Li","is_ca":false},{"name":"Laura Morrison","is_ca":true},{"name":"Bruno Émond","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Annalise Hilts","is_ca":true},{"name":"Jill Korsiak","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Pratyusha Vadagam","is_ca":false},{"name":"Dexter Waters","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0543748553438399,"gpt":0.444466954937541,"spread":0.3900920995937011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004062723,0.0002105183,0.0003114829,0.001464111,0.0002919159,0.000753084,0.0003599883,0.0003782038,0.002328701],"category_scores_gemma":[0.002349085,0.0001598749,0.0006648831,0.003308194,0.00016945,0.0007195614,0.0004886278,0.000363215,0.000259641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009722091,"about_ca_system_score_gemma":0.0005071457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01767327,"about_ca_topic_score_gemma":0.01781314,"domain_scores_codex":[0.9992923,0.0001899924,0.0001754612,0.0001197348,0.0001072074,0.0001152843],"domain_scores_gemma":[0.9983079,0.0003571199,0.0009952397,0.00003710442,0.0001032429,0.0001992474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001389969,0.00005987694,0.9974777,0.00002530347,0.00009152346,0.0000534359,0.0000484466,0.0003198964,0.00002979044,0.00004280738,0.0003976265,0.001314597],"study_design_scores_gemma":[0.00001649617,0.00009860317,0.9975255,0.00002212671,0.00003890961,0.0001566491,0.0003214166,0.001249568,0.00004070493,0.00006077378,0.0004617023,0.000007555485],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916304,0.0003546676,0.00004220038,0.0001064183,0.000002848796,0.00001878963,0.007261262,0.000003137518,0.0005803206],"genre_scores_gemma":[0.9944614,0.0002758794,0.00008389766,0.00006187176,0.00001033115,0.00004709299,0.004897209,0.000001553669,0.0001608579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01767327,"threshold_uncertainty_score":0.03514081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981257856","doi":"10.36469/9844","title":"The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"Bristol-Myers Squibb","keywords":"Medicine; Medical Expenditure Panel Survey; Diagnosis code; Prostate cancer; Chemotherapy; Cancer; Disease; Health care; Population; Internal medicine; Multivariate analysis; Indirect costs; Oncology; Health insurance; Environmental health","authors":[{"name":"Peter J. Mallow","is_ca":false},{"name":"Jie Chen","is_ca":false},{"name":"John A. Rizzo","is_ca":false},{"name":"John R. Penrod","is_ca":false},{"name":"Géralyn C. Trudel","is_ca":true},{"name":"Teresa Zyczynski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2482978177145586,"gpt":0.4433187084434752,"spread":0.1950208907289165,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003492201,0.0004020379,0.0004270807,0.002567903,0.0001658285,0.0005453515,0.0005285305,0.0002741257,0.001468692],"category_scores_gemma":[0.01601323,0.0002711117,0.001613652,0.004655123,0.0002652692,0.0005411389,0.0008807422,0.0005357371,0.0001399895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008198375,"about_ca_system_score_gemma":0.0009761275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02589418,"about_ca_topic_score_gemma":0.04603425,"domain_scores_codex":[0.9973049,0.001288747,0.0003578086,0.0001931219,0.0007127548,0.0001425616],"domain_scores_gemma":[0.9857047,0.004877284,0.006832589,0.0004929129,0.001585303,0.000507342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001195876,0.00002729413,0.9858445,0.0004132616,0.001149272,0.00001776483,0.00002480695,0.0005841984,0.000009197211,0.00008837716,0.002042015,0.009679687],"study_design_scores_gemma":[0.00001546191,0.00004759399,0.9966123,0.0002716557,0.000503257,0.00006537743,0.00005747357,0.0005942212,0.00002200387,0.00009445168,0.001710034,0.00000620027],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9068139,0.05518059,0.0007254458,0.00364875,0.0001213896,0.00008963413,0.02872482,0.00003018646,0.004665278],"genre_scores_gemma":[0.9773093,0.01227644,0.0003304369,0.0003354693,0.00007656121,0.00003264447,0.009474167,0.000004934532,0.0001600753],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02589418,"threshold_uncertainty_score":0.05148697,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7117448944","doi":"10.36469/001c.151273","title":"Comparison of Prostate-Specific Antigen Response in Black Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone Acetate","year":2025,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Abiraterone acetate; Prostate cancer; Abiraterone; Prostate-specific antigen; Antiandrogen; Clinical trial","authors":[{"name":"Gordon Brown","is_ca":false},{"name":"Sabree Burbage","is_ca":false},{"name":"Ibrahim Khilfeh","is_ca":false},{"name":"Carmine Rossi","is_ca":true},{"name":"Shawn Du","is_ca":false},{"name":"Frédéric Kinkead","is_ca":true},{"name":"Lilián Díaz","is_ca":true},{"name":"Dominic Pilon","is_ca":true},{"name":"Benjamin Lowentritt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193152931811868,"gpt":0.4601957210993868,"spread":0.3408804279182001,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009960814,0.0001985738,0.0003764071,0.0005643621,0.0002287541,0.0004249642,0.0002952267,0.0002713744,0.0009630875],"category_scores_gemma":[0.002836851,0.0001517244,0.0006061104,0.0005474245,0.000168235,0.000309528,0.0003113291,0.0004258284,0.000126009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005017907,"about_ca_system_score_gemma":0.0003516551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003121033,"about_ca_topic_score_gemma":0.003439774,"domain_scores_codex":[0.9993898,0.0002026898,0.0000480393,0.0001463557,0.0001097566,0.000103395],"domain_scores_gemma":[0.9978694,0.0004526021,0.00119682,0.00007648988,0.0001338972,0.0002708083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005220274,0.0001356084,0.9887284,0.00002801829,0.0003781326,0.00004666851,0.0001088597,0.0002480926,0.0008409353,0.00004113877,0.000106862,0.004116891],"study_design_scores_gemma":[0.0001372199,0.00147743,0.9966953,0.000009950933,0.0001989099,0.0001632779,0.0001248426,0.0005058101,0.0002932396,0.00004983991,0.0003380398,0.000006170948],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993777,0.0001614803,0.00004326721,0.00001789058,0.000002853156,0.00000662544,0.0002299701,0.000001468796,0.0001585156],"genre_scores_gemma":[0.9994264,0.0000676681,0.00003899183,0.00002221293,0.00000694517,0.000008665259,0.0003600096,0.000001346032,0.00006796904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003121033,"threshold_uncertainty_score":0.006205678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2980833094","doi":"10.36469/9820","title":"A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Takeda Oncology; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma","authors":[{"name":"Margaret Hux","is_ca":false},{"name":"Denise Zou","is_ca":false},{"name":"Esprit Ma","is_ca":false},{"name":"Peter Sajosi","is_ca":false},{"name":"Andreas Engström","is_ca":false},{"name":"Ross Selby","is_ca":false},{"name":"Eugene Benson","is_ca":false},{"name":"Andrew Briggs","is_ca":false},{"name":"Vijayveer Bonthapally","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09011777675505077,"gpt":0.4229909358078391,"spread":0.3328731590527883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005611343,0.001484295,0.001854338,0.00139281,0.0002108863,0.001765136,0.0009826153,0.001219745,0.00338306],"category_scores_gemma":[0.01301819,0.0007109054,0.00434285,0.001034624,0.0004978034,0.001324185,0.000882144,0.001245184,0.0001533888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007717357,"about_ca_system_score_gemma":0.002595695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01196343,"about_ca_topic_score_gemma":0.008200807,"domain_scores_codex":[0.9964563,0.002858636,0.00009808148,0.0001841237,0.0001993909,0.0002033154],"domain_scores_gemma":[0.9938059,0.005296545,0.0004121037,0.00009179304,0.0001687032,0.0002249589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02530949,0.0007472584,0.0137948,0.003875619,0.008797701,0.00064505,0.00009853522,0.8929099,0.001225399,0.004543962,0.00163385,0.0464185],"study_design_scores_gemma":[0.009064101,0.01272536,0.02632503,0.001957633,0.01387213,0.0009529397,0.0004212689,0.9212955,0.001037358,0.007281849,0.004894421,0.0001724336],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9294314,0.03830695,0.01550926,0.002902959,0.0002098824,0.001428656,0.003903504,0.0001092546,0.008198187],"genre_scores_gemma":[0.9948645,0.002048131,0.001811985,0.0001680117,0.00002287989,0.0001639832,0.0005444912,0.000008371107,0.0003675339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01196343,"threshold_uncertainty_score":0.05599362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412855801","doi":"10.36469/001c.141170","title":"Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Hazard ratio; Abiraterone acetate; Oncology; Urology; Prostate-specific antigen; Internal medicine; Confidence interval; Cancer; Prostate; Androgen deprivation therapy; Androgen receptor","authors":[{"name":"Shawn Du","is_ca":false},{"name":"Carmine Rossi","is_ca":true},{"name":"Ibrahim Khilfeh","is_ca":false},{"name":"Porpong Boonmak","is_ca":true},{"name":"Gordon Wong","is_ca":true},{"name":"Dominic Pilon","is_ca":true},{"name":"Lorie Ellis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0523072026035814,"gpt":0.4133969229166968,"spread":0.3610897203131154,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001598463,0.0004540698,0.0005205609,0.0008882597,0.0003071782,0.0008512581,0.0007116792,0.0005614373,0.001169005],"category_scores_gemma":[0.00356386,0.0003323361,0.001239731,0.001041958,0.0003986377,0.0008219691,0.0009585297,0.0005782389,0.00019632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007344658,"about_ca_system_score_gemma":0.0004557988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006077487,"about_ca_topic_score_gemma":0.006978171,"domain_scores_codex":[0.9985527,0.0005168419,0.0001663573,0.0004131593,0.0001597991,0.0001910514],"domain_scores_gemma":[0.9973797,0.0004320542,0.00143679,0.0001866334,0.0001493274,0.0004154793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002772768,0.0001344913,0.9944686,0.00002911006,0.0005967778,0.00003438774,0.00008864119,0.0002108243,0.0001488984,0.00003155936,0.0001061514,0.00137778],"study_design_scores_gemma":[0.0001767524,0.0008063035,0.9971726,0.00001053642,0.0002091875,0.0001302094,0.0002031608,0.0009319632,0.00007843013,0.00005434862,0.0002126855,0.00001388098],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992055,0.0001462129,0.00005320127,0.00001589466,0.000005446402,0.00001822392,0.0004353678,0.000001625074,0.0001183705],"genre_scores_gemma":[0.9990447,0.00004839664,0.00003842708,0.00001178822,0.000007483171,0.00001691166,0.0007890979,0.000001058969,0.00004218167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006077487,"threshold_uncertainty_score":0.01208425,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407253168","doi":"10.36469/001c.127820","title":"Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Medicine; Psoriasis; Retrospective cohort study; Cohort; Medical prescription; Prescription drug; Family medicine; Internal medicine; Dermatology; Pharmacology","authors":[{"name":"Laurence Mainville","is_ca":true},{"name":"Hélène Veillette","is_ca":true},{"name":"Paul R. Fortin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03267356853526875,"gpt":0.3606414399190919,"spread":0.3279678713838231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008524404,0.0003980027,0.000612467,0.001462079,0.001289183,0.0008830489,0.0006676306,0.000486108,0.002212122],"category_scores_gemma":[0.002022092,0.0005033896,0.0006478149,0.003311052,0.0004983007,0.0005663292,0.0006202012,0.0006936686,0.0002858284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001706008,"about_ca_system_score_gemma":0.001982174,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1689404,"about_ca_topic_score_gemma":0.1793137,"domain_scores_codex":[0.9987932,0.0001442435,0.000133715,0.0003674325,0.000284419,0.0002769065],"domain_scores_gemma":[0.9982736,0.000196128,0.0007021363,0.0001888128,0.0003145432,0.0003247982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008012688,0.00003468533,0.9987924,0.00001993517,0.0000771859,0.0001067234,0.00008362318,0.00001432772,0.00007079148,0.00001373282,0.0001649745,0.0005413924],"study_design_scores_gemma":[0.00002004828,0.00009486015,0.9986044,0.00002197344,0.00008253218,0.0003797823,0.0002834114,0.0001144071,0.00002177547,0.00001578098,0.0003531923,0.00000775774],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970769,0.0006021813,0.0001433307,0.00005228602,0.000009916405,0.0001074561,0.001487778,0.000004808275,0.0005153412],"genre_scores_gemma":[0.9984587,0.0002612874,0.0001311776,0.00006738547,0.00001380825,0.00005236278,0.0008856172,0.000002677081,0.0001269257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1689404,"threshold_uncertainty_score":0.3359141,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407240390","doi":"10.36469/jheor.2025.127820","title":"Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Psoriasis; Retrospective cohort study; Medicine; Drug; Cohort; Internal medicine; Dermatology; Pharmacology","authors":[{"name":"Laurence Mainville","is_ca":false},{"name":"Hélène Veillette","is_ca":false},{"name":"Paul R. Fortin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03267356853526875,"gpt":0.3606414399190919,"spread":0.3279678713838231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008837348,0.0003888156,0.0005832254,0.00138675,0.001351719,0.0009150534,0.0006591725,0.0004866906,0.002054123],"category_scores_gemma":[0.002012994,0.000503324,0.0006321761,0.003078973,0.0005299364,0.0005699407,0.0006396104,0.0007174303,0.0002765423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001767965,"about_ca_system_score_gemma":0.002146053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1739842,"about_ca_topic_score_gemma":0.1818237,"domain_scores_codex":[0.9988059,0.0001405003,0.0001246588,0.0003647858,0.0002913205,0.0002728434],"domain_scores_gemma":[0.9981928,0.0001969169,0.0007600273,0.0002043819,0.0003235023,0.0003222737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008136879,0.00003228731,0.9989643,0.00001489734,0.00006694037,0.00009239402,0.00008114235,0.0000122871,0.00006661616,0.00001189899,0.0001482447,0.0004276595],"study_design_scores_gemma":[0.00001879894,0.00009812033,0.9986752,0.00001839994,0.00007187056,0.0003632421,0.0003037596,0.000106794,0.00002135905,0.00001373053,0.0003016931,0.000007021194],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976259,0.0004278185,0.0001125033,0.00004545827,0.000007951448,0.00008084608,0.001252909,0.000003877499,0.0004427531],"genre_scores_gemma":[0.9986759,0.0001997945,0.0001077222,0.00006139199,0.00001095431,0.00004149338,0.0007823315,0.000002490194,0.0001180127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1739842,"threshold_uncertainty_score":0.3459429,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323765291","doi":"10.36469/jheor.2019.9744","title":"Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism","year":2019,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Janssen Scientific Affairs","keywords":"Medicine; Pulmonary embolism; Confidence interval; Odds ratio; Pulmonary angiography; Internal medicine; Logistic regression; Cardiology","authors":[{"name":"Li Wang","is_ca":false},{"name":"Onur Başer","is_ca":false},{"name":"Philip S. Wells","is_ca":true},{"name":"W. Frank Peacock","is_ca":false},{"name":"Craig I Coleman","is_ca":false},{"name":"Gregory J. Fermann","is_ca":false},{"name":"Jeff Schein","is_ca":false},{"name":"Concetta Crivera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01216100580515167,"gpt":0.305075553548598,"spread":0.2929145477434463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000381498,0.0001948605,0.0001935927,0.0004337415,0.0002082229,0.0005009858,0.0002789462,0.0003014311,0.001704873],"category_scores_gemma":[0.003207591,0.0001100814,0.0002469356,0.0005515994,0.0001477519,0.0003184285,0.0003307295,0.0006180942,0.0001597281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002785813,"about_ca_system_score_gemma":0.0003562305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003156869,"about_ca_topic_score_gemma":0.004123289,"domain_scores_codex":[0.9997409,0.00006163619,0.00004465126,0.00003919363,0.00005402875,0.00005960418],"domain_scores_gemma":[0.9974396,0.0004491137,0.00146501,0.00005080328,0.0002084108,0.0003870326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002217333,0.000007094305,0.9996074,0.000002883967,0.000007907313,0.00001397028,0.000006400198,0.00002219002,0.00002023983,0.000004437166,0.00003924928,0.0002461409],"study_design_scores_gemma":[0.000003060922,0.00004492552,0.9992967,0.000007973086,0.00001067566,0.0001580419,0.00006896438,0.0003081104,0.00002036063,0.00002171893,0.00005770273,0.000001814633],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999248,0.0002369691,0.00004932686,0.00009108985,0.000004480603,0.000002814561,0.0002033914,0.000002142422,0.0001616431],"genre_scores_gemma":[0.9996378,0.00005502678,0.00003582352,0.00001317043,0.000007440186,0.000002115982,0.0002137237,5.788477e-7,0.00003433938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003156869,"threshold_uncertainty_score":0.006276965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W34993257","doi":"10.36469/jheor.2021.29145","title":"近代自然科学与传统学术的现代转型―以章太炎、康有为、梁启超为例","year":2009,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Computer science","authors":[{"name":"张秀丽","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.117271174130939,"gpt":0.4804030909012495,"spread":0.3631319167703105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0003674025,0.0002434015,0.000225712,0.001568576,0.001259866,0.0009646266,0.0005699266,0.0002048738,0.007481342],"category_scores_gemma":[0.002108648,0.0001614491,0.0004039478,0.004295183,0.0004588154,0.0003168206,0.0005979112,0.0002755995,0.0005585838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01857369,"about_ca_system_score_gemma":0.02181739,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.9678,"about_ca_topic_score_gemma":0.9857876,"domain_scores_codex":[0.99938,0.0000411275,0.00005732074,0.00006136799,0.0003141803,0.0001459932],"domain_scores_gemma":[0.9984471,0.00009429371,0.0006543861,0.0000369237,0.0005225819,0.0002446754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006329326,0.00002701043,0.9624317,0.0003415711,0.0001123157,0.0001234559,0.0003488596,0.0003534649,0.0002195033,0.0004614185,0.01726714,0.01825026],"study_design_scores_gemma":[0.00001229842,0.00002279853,0.9845471,0.0001807929,0.0000515237,0.0001592392,0.0007256641,0.0004130772,0.0001071707,0.00009713251,0.01367289,0.00001021313],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8389229,0.003145186,0.0007922807,0.003132013,0.00006201505,0.0003312022,0.1244418,0.00008596202,0.02908661],"genre_scores_gemma":[0.9569107,0.003198668,0.001381562,0.0005897494,0.00003866161,0.0001591016,0.03165559,0.00001490059,0.006051057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9987401,"threshold_uncertainty_score":0.1347622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}